First Time Loading...

Trinity Biotech PLC
NASDAQ:TRIB

Watchlist Manager
Trinity Biotech PLC Logo
Trinity Biotech PLC
NASDAQ:TRIB
Watchlist
Price: 2.04 USD 3.03% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. [ Read More ]

The intrinsic value of one TRIB stock under the Base Case scenario is 4.34 USD. Compared to the current market price of 2.04 USD, Trinity Biotech PLC is Undervalued by 53%.

Key Points:
TRIB Intrinsic Value
Base Case
4.34 USD
Undervaluation 53%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Trinity Biotech PLC

Backtest TRIB Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling TRIB stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Trinity Biotech PLC's business.

What risks and challenges
does Trinity Biotech PLC face in the near future?

Summarize the latest earnings report
of Trinity Biotech PLC.

Provide P/E
for Trinity Biotech PLC and its competitors.

Financials

Balance Sheet Decomposition
Trinity Biotech PLC

Current Assets 43.8m
Cash & Short-Term Investments 6.3m
Receivables 16.7m
Other Current Assets 20.9m
Non-Current Assets 19.8m
PP&E 1.8m
Intangibles 16.2m
Other Non-Current Assets 1.8m
Current Liabilities 12.7m
Accounts Payable 10.6m
Other Current Liabilities 2.1m
Non-Current Liabilities 68.3m
Long-Term Debt 65.2m
Other Non-Current Liabilities 3.1m
Efficiency

Earnings Waterfall
Trinity Biotech PLC

Revenue
61.4m USD
Cost of Revenue
-40.3m USD
Gross Profit
21.1m USD
Operating Expenses
-38.4m USD
Operating Income
-17.2m USD
Other Expenses
-11.4m USD
Net Income
-28.6m USD

Free Cash Flow Analysis
Trinity Biotech PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

TRIB Profitability Score
Profitability Due Diligence

Trinity Biotech PLC's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional ROE
Positive Gross Profit
ROE is Increasing
50/100
Profitability
Score

Trinity Biotech PLC's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

TRIB Solvency Score
Solvency Due Diligence

Trinity Biotech PLC's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
36/100
Solvency
Score

Trinity Biotech PLC's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TRIB Price Targets Summary
Trinity Biotech PLC

Wall Street analysts forecast TRIB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TRIB is 3 USD .

Lowest
Price Target
Not Available
Average
Price Target
3 USD
47% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

TRIB Price
Trinity Biotech PLC

1M 1M
-6%
6M 6M
-44%
1Y 1Y
-54%
3Y 3Y
-90%
5Y 5Y
-86%
10Y 10Y
-98%
Annual Price Range
2.04
52w Low
1.8775
52w High
5.7
Price Metrics
Average Annual Return 22.12%
Standard Deviation of Annual Returns 144.46%
Max Drawdown -94%
Shares Statistics
Market Capitalization 77.9m USD
Shares Outstanding 38 207 600
Percentage of Shares Shorted 1.8%

TRIB Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Trinity Biotech PLC Logo
Trinity Biotech PLC

Country

Ireland

Industry

Health Care

Market Cap

77.9m USD

Dividend Yield

0%

Description

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The company is headquartered in Bray, Wicklow. The firm's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The company operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business.

Contact

WICKLOW
BRAY
Ida Business Park, Bray, Co Wicklow, Ireland
+1135312955111.0
https://www.trinitybiotech.com/

IPO

1992-10-21

Employees

543

Officers

President, CEO, Company Secretary & Director
Mr. John Gillard
Founder & Director
Mr. Ronan O'Caoimh
Executive Director of Business Development & Executive Director
Dr. James Walsh Ph.D.
Interim Chief Financial Officer
Mr. Des Fitzgerald
Chief Accounting Officer
Mr. Simon Dunne
Chief Technology Officer
Dr. Gary Keating Ph.D.
Show More
Chief Information Officer
Ms. Eibhlin Kelly
Group Director of Human Resources & Culture
Mr. Colm Molloy
Show Less

See Also

Discover More
What is the Intrinsic Value of one TRIB stock?

The intrinsic value of one TRIB stock under the Base Case scenario is 4.34 USD.

Is TRIB stock undervalued or overvalued?

Compared to the current market price of 2.04 USD, Trinity Biotech PLC is Undervalued by 53%.